mybacs

mybacs

Signal active

Organization

Contact Information

Overview

mybacs is a DTC, research-driven, Biotechnology company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.

About

Industries

E-Commerce, Biotechnology, Shopping, Health Care

Founded

2019

Employees

11-50

Headquarters locations

Zug, Zug, Switzerland, Europe

Social

Profile Resume

mybacs headquartered in Zug, Switzerland, Europe, operates in the E-Commerce, Biotechnology, Shopping, Health Care sector. The company focuses on E-Commerce and has secured $366.6M in funding across 48 round(s). With a team of 11-50 employees, mybacs is actively contributing to advancements in E-Commerce. Their latest funding round, Series A - mybacs, raised $5.9M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Carl-Philipp von Polheim

Carl-Philipp von Polheim

Founder and Co-CEO

imagePlace Sebastian Wahl

Sebastian Wahl

Founder

Funding Rounds

Funding rounds

3

Investors

5

Lead Investors

0

Total Funding Amount

$7.6M

Details

3

mybacs has raised a total of $7.6M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Seed778.0K
2020Seed960.0K
2023Early Stage Venture5.9M

Investors

mybacs is funded by 13 investors.

Investor NameLead InvestorFunding RoundPartners
WENVEST Capital-FUNDING ROUND - WENVEST Capital5.9M
Joyance Partners-FUNDING ROUND - Joyance Partners5.9M
mybacs-FUNDING ROUND - mybacs5.9M
SevenVentures-FUNDING ROUND - SevenVentures5.9M